Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BAZ1A | Q9NRL2 | 1/20 | 0.60 |
| ▸ | MAPT | P10636 | 6/20 | 0.55 |
| ▸ | HTT | P42858 | 4/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | PKM | P14618 | 1/20 | 0.55 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.55 |
| ▸ | CASP6 | P55212 | 1/20 | 0.55 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.55 |
| ▸ | RELA | Q04206 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 5/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | CASP1 | P29466 | 1/20 | 0.55 |
| ▸ | CASP7 | P55210 | 1/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30626616 | 1.00 | BAZ1A (0.60) | BAZ1AMAPTHTTTDP1RAB9A | |
| Hydrochloric Acid SCHEMBL27777744 | 0.98 | BAZ1A (0.59) | BAZ1AMAPTHTTTDP1RAB9A | |
| Formaldehyde SCHEMBL27533960 | 0.97 | BAZ1A (0.58) | BAZ1AMAPTHTTTDP1RAB9A | |
| Quinoline SCHEMBL28125811 | 0.95 | ALDH1A1 (0.57) | BAZ1AMAPTHTTTDP1RAB9A | |
| SCHEMBL366012 | 0.86 | ALDH1A1 (0.62) | BAZ1AMAPTHTTTDP1RAB9A | |
| Quinoline SCHEMBL9110133 | 0.85 | ALDH1A1 (0.66) | BAZ1AMAPTHTTTDP1RAB9A | |
| Hydrochloric Acid SCHEMBL27777765 | 0.84 | ALDH1A1 (0.60) | BAZ1AMAPTHTTTDP1RAB9A | |
| SCHEMBL11012641 | 0.83 | ALDH1A1 (0.51) | BAZ1AMAPTHTTTDP1RAB9A | |
| Dinitrophenylene SCHEMBL27728956 | 0.83 | ALDH1A1 (0.58) | BAZ1AMAPTHTTTDP1RAB9A | |
| SCHEMBL9040936 | 0.81 | KMT2A (0.61) | BAZ1AMAPTRAB9ANPC1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | BASF SE (DE) | 2019-03-05 | — | — | US | claimed |
| CN-108727262-A | A kind of synthetic method of the bromo- 7- methoxy quinolines of 3- | 苏州康润医药有限公司 | 2018-11-02 | — | — | CN | claimed |
| US-20170012208-A1 | ORGANIC SEMICONDUCTOR FORMULATIONS | USINVEST LLC | 2017-01-12 | — | — | US | claimed |
| CN-102911116-A | Metal-chelated azo compact disc dye preparation method | SHANGHAI YONGHONG INDUSTRY GROUP CHEMICAL TECHNOLOGY CO LTD | 2013-02-06 | — | — | CN | claimed |
| US-7732534-B2 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2010-06-08 | — | — | US | claimed |
| US-20080051519-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION (JP) | 2008-02-28 | — | — | US | claimed |
| US-20080051552-A1 | Polymers functionalized with nitro compounds | BRIDGESTONE CORPORATION | 2008-02-28 | — | — | US | claimed |
| CN-122059875-A | Method for synthesizing quinoline compound by catalytic dehydrogenation of tetrahydroquinoline compound | 西安石油大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-120757496-A | Synthesis method of medicine intermediate 7-nitro-3- (trifluoromethyl) quinoline | 福建凯昕药业有限公司 | 2025-10-10 | — | — | CN | disclosed |
| CN-120035438-A | Use of 8-hydroxyquinoline derivatives | 江苏亚虹医药科技股份有限公司 | 2025-05-23 | — | — | CN | disclosed |
| CN-119661432-A | PRMT5 inhibitor, and pharmaceutical composition, pharmaceutical preparation and application thereof | 北京福元医药股份有限公司 | 2025-03-21 | — | — | CN | disclosed |
| WO-2024132001-A1 | MULTITARGET NUCLEAR RECEPTOR LIGANDS BASED ON 2-(4-(QUINOLIN-2-YLOXY)PHENOXY)PROPANOIC ACID AND 2-(4-(QUINOXALIN-2-YLOXY)PHENOXY)PROPANOIC ACID FOR THE TREATMENT OF METABOLIC AND LIVER DISEASES | CHARLES UNIVERSITY, FACULTY OF PHARMACY IN HRADEC KRALOVE (CZ) | 2024-06-27 | — | — | WO | disclosed |
| CN-118059101-A | Use of 8-hydroxyquinoline derivatives | 江苏亚虹医药科技股份有限公司 | 2024-05-24 | — | — | CN | disclosed |
| EP-0858998-A1 | Separation of 5-nitroquinoline and 8-nitroquinoline | ELI LILLY AND COMPANY (US) | 1998-08-19 | — | — | EP | disclosed |
| WO-1998033773-A1 | SEPARATION OF 5-NITROQUINOLINE AND 8-NITROQUINOLINE | ELI LILLY AND COMPANY (US) | 1998-08-06 | — | — | WO | disclosed |
| US-5405843-A | Anticancer drug potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0363212-B1 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-5204348-A | Quinoline derivatives | MITSUI TOATSU CHEMICALS INC. (JP) | 1993-04-20 | — | — | US | disclosed |
| US-5112817-A | Anticancer Drug Potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1992-05-12 | — | — | US | disclosed |
| EP-0363212-A2 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1990-04-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10224485-B2 | Process for preparing a crystalline organic semiconductor material | STOM, SPOP, TTR | BAZ1A 4652/4885MAPT 150/4885HTT 2419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.